Fulgent Genetics (FLGT) Cash from Discontinued Operations (2015 - 2016)
Fulgent Genetics' (FLGT) quarterly Cash from Discontinued Operations came in at -$14000.0 in Q2 2016, up 17.65% quarter-over-quarter from -$17000.0 in Q1 2016.
Powered by 
Analysis
Fulgent Genetics (FLGT) Cash from Discontinued Operations (2015 - 2016) Analysis & Trends
Fulgent Genetics has disclosed Cash from Discontinued Operations across 2 years of filings, most recently posting -$14000.0 for Q2 2016.
- In Q2 2016, Cash from Discontinued Operations changed N/A year-over-year to -$14000.0; the TTM figure through Dec 2016 stood at -$31000.0 (changed N/A YoY), while the FY2016 annual figure was -$31000.0, up 98.96% from the prior year.
- Cash from Discontinued Operations came in at -$14000.0 for Q2 2016 at Fulgent Genetics, up from -$17000.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of -$14000.0 in Q2 2016 to a low of -$916000.0 in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | - |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | - |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | - |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | -14,000.00 |
| Mar 31, 2016 | -17,000.00 |
| Dec 31, 2015 | -916,000.00 |